Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03066518Phase 4Completed
Phase 4, randomised, double-blind trial in Insomnia comparing Melatonin with Placebo (2 arms). Primary endpoint: Pittsburgh Sleep Quality Index at 8 weeks. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03066518.